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Metastatic breast carcinoma has a great tendency to spread to the mandible. It is concomitantly associated with bone destruction, food intake disorder, and a poorer 
prognosis. Appropriate animal models need to be developed for a better understanding of 
the mechanisms underlying the metastatic process of breast cancer cells to mandible and 
to test the effects of potential lead compounds. Here, we assessed the metastasis model 
of intracardiac injection using luciferase-transfected metastatic breast cancer cells (MDA-
MB-231Luc+) by determining the incidences of metastasis, mCT images, and histopathological 
results. A high bioluminescence signal mainly detected mandibular lesions with less frequent 
distal femora and proximal tibiae lesions. Extensive mandibular bone destruction occurred 
in nude mice grafted with metastatic breast cancer cells. This type of animal model might 
be a useful tool in assessing therapeutic implications and the efficacy of anti-cancer drugs 
for osteolytic cancers. 
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INTRODUCTION
Bone is one of the most common sites for 
metastasis29. Bone metastases represent a major 
complication of malignant tumors. Metastatic 
tumors to the mandibles not a uncommon 
phenomenon and account for approximately 1% 
of all malignant oral tumors27. Metastatic tumors 
in the mandible are more frequently reported than 
those in the oral mucosa. In particular, breast 
carcinoma metastasizes to the mandible three times 
as often as any other malignant tumor1. However, 
the pathogenesis of the metastatic process in the 
mandible remains unclear. Metastatic tumors to the 
oral region are challenging and difficult to diagnose 
because of their relative infrequency. Therefore, 
they should be considered in the differential 
diagnosis of inflammatory and reactive lesions that 
are common to the oral region.
In the meantime, most of the currently available 
metastatic animal models of human breast tumor 
xenografts using orthotopic transplantation have 
only a limited success rate in most trials. The intra-
tibia inoculation of breast cancer as a cancer-bone 
metastasis model fails to address certain aspects of 
the clinical situation and does not precisely reflect 
the characteristics of metastatic breast cancer8,13. 
Appropriate animal models are currently insufficient 
for the research before clinical trials. Thus, a 
feasible and adequate metastatic animal model 
needs to serve as a suitable tool to help precisely 
understand the molecular mechanism of mandible 
bone metastasis of breast cancer and to develop 
new therapeutic agents against metastatic breast 
cancer to bone.
In this study, we assessed the metastasis model 
of intracardiac injection using luciferase-transfected 
metastatic breast cancer cells, demonstrated its 
value as a useful in vivo tool for metastatic breast 
cancer to mandible bone, and examined the 
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histopathological aspect. This type of animal model 
approach might have the additional advantage of 
potentially accelerating the biological discovery 
process.
MATERIAL AND METHODS
Material and reagents
Dulbecco’s modified Eagle’s medium (DMEM), 
Hank’s balanced salt solution (HBSS), fetal bovine 
serum (FBS), antibiotic-antimycotic mixture 
containing 100 U/ml penicillin and 100 ml/ml 
streptomycin, phosphate-buffered saline (PBS), and 
0.25% trypsin-EDTA were purchased from Gibco 
BRL Co. (Rockville, MD, USA). D-Luciferin potassium 
salt was obtained from Goldbio Technology (St. 
Louis, MO, USA). DMSO and all other chemicals 
were purchased from Sigma-Aldrich (St. Louis, 
MO, USA). All reagents used in this research were 
of analytical grade.
Cell culture
The human mammary carcinoma cell line 
MDA-MB-231 was obtained from the Korean Cell 
Line Bank (Seoul, Korea) and cultured in DMEM 
supplemented with 10% FBS at 37°C under a 
humidified atmosphere of 5% CO2.
Luciferase vector construction
To generate the lentiviral particles with lentiviral 
vector-based luciferase, firefly luciferase gene 
from Photinus pyralis was amplified by polymerase 
chain reaction (PCR)-based methods using pTAL-
Luc vector (Clontech, Palo Alto, CA, USA) as a 
template, followed by subcloning into the pLenti6/
V5 Directional TOPO Cloning vector in ViraPowerTM 
Lentiviral Expression Systems (Invitrogen, Carlsbad, 
CA, USA). pLenti6/V5-Luc plasmid was subjected 
to DNA sequencing analysis to confirm a successful 
construction. Lentivirus particles were produced 
by cotransfecting the 293FT producer cell line 
with pLenti6/V5-Luc plasmid and the ViraPowerTM 
Packaging Mix. The cells were transducted using 
2×107 lentiviral particles with transduction enhancer 
Polybrene at 10 mg/ml to establish luciferase-
transfected MDA-MB-231 (MDA-MB-231Luc+) stable 
cells. Blasticidine (10 mg/ml) was added to select 
stably transduced cells. Blasticidine-resistance 
clones exhibited the V5 epitope detection against 
anti-V5 antibody by western blot analysis and 
revealed the maximum level of luciferase activity 
using a microplate spectrofluorometer (Molecular 
Devices, Palo Alto, CA, USA).
Animals
Female Balb/c nu/nu mice (5 weeks of age) were 
purchased from Nara Bio Inc. (Seoul, Korea) and 
maintained at 20-22°C on a 12 h light/dark cycle. 
All animal studies were performed in accordance 
with experimental protocols that were approved by 
the animal ethics committee of Yonsei University 
College of Dentistry.
Animal model of the metastatic breast 
cancer to the mandible
Mice were anesthetized by intramuscular 
injection of a mixture with 30 mg/kg Zoletil 
(Verbac, Carros, France) and 10 mg/kg xylazine 
(Bayer Korea, Seoul, Korea). MDA-MB-231Luc+ cells 
(1×106 cells/0.1 ml in HBSS) were injected into the 
left cardiac ventricle of nude mice with a 26-1/2 
gauge needle according to the modification of the 
method3. Metastatic progression in nude mice was 
shown with bioluminescence imaging on 6 weeks 
after intracardiac injection. Then all animals were 
euthanized by CO2 asphyxiation and histological 
analysis was performed.
Bioluminescent imaging
Bioluminescent in vivo imaging was detected 
with a highly sensitive CCD camera mounted in 
a light-tight specimen box (IVIS-200TM, Xenogen, 
Caliper Life Sciences, Alameda, CA, USA). Animals 
were given the substrate D-Luciferin potassium 
salt by intraperitoneal injection of 150 mg/kg in 
Dulbecco’s Phosphate Buffered Saline and then 
they were anesthetized with 1-3% isoflurane gas. 
Ten min after the D-Luciferin injection, mice were 
placed onto the warmed stage inside the light-tight 
camera box with continuous exposure to 1-2% 
isoflurane gas.
mCT analysis
The mandibles of the nude mice were scanned 
using a Skyscan 1076 high-resolution mCT with 100 
Kv, 140 mA current, rotation step 0.6o and camera 
pixel size 35 mm (SkyScan, Antwerpen, Belgium). 
NRecon and CT analyzer (CTAn) software (SkyScan) 
were used to analyze the structure of the sample. 
Two-dimensional images were used to generate 
three-dimensional (3-D) reconstructions with the 
software. The bone volume (BV) was calculated 
from the processed images shown in 3-D image 
using CTAn software with the same diameter given.
Hematoxylin and eosin (H&E) staining
The tissues were fixed in 10% buffered formalin 
solution and embedded in paraffin. Tissue sections 
(4 mm thickness) were sectioned using a Leica 2135 
microtome, deparaffinized in xylene, rehydrated 
through an alcohol series, and stained with H&E 
for histopathology. Then, tissues were dehydrated 
and mounted.
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Statistical analysis
The statistical analysis was conducted using 
InStat™ statistical software (GraphPad Software, 
Inc., San Diego, CA, USA), and results are 
expressed as mean±standard error. The statistical 
significance of differences between groups was 
analyzed via repeated measures of Student’s 
paired and unpaired t-tests. Asterisks were used to 
graphically indicate statistical significance. P values 
of <0.05 were considered significant.
RESULTS
Mouse model for metastatic breast cancer 
to the mandible
MDA-MB-231Luc+ cells were inoculated into 
the left ventricle of mice and the metastatic 
progression of breast cancer was tracked through 
bioluminescence imaging using an IVIS Imaging 
System (Figure 1). Metastasis to mandible were 
detected in all mice injected with MDA-MB-231Luc+ 
cells (n=250). A high level of total photon flux was 
observed following the injection of MDA-MB-231Luc+ 
cells (P<0.001). Multiple organ metastases were 
frequently observed in distal femora and proximal 
tibiae. The high bioluminescence signal was also 
mainly observed in mandibles.
Mandible bone analysis usingmCT
The mCT images afforded a nondestructive 
visualization of the changes that occurred over the 
entire mandible. Osteolytic lesions of mice were 
analyzed by radiography at 6 weeks after cancer 
cell injection. On the mediolateral radiograph, an 
extensive bone destruction was observed around 
the mandibular bone in mice injected with MDA-
MB-231Luc+ cells (Figure 2A). Osteolytic lesions 
occurred in both cancellous and cortical bones 
on vertical projection (slice) (Figure 2A) and 3-D 
reconstruction images (Figure 2B). The bone 
volume was determined from the processed images 
shown in Figure 2B using CTAn software with the 
same diameter given as where bioluminescence 
signal and osteolytic site were overlapping (Figure 
2C). The total bone volume was decreased about 
28.9% in mice injected with MDA-MB-231Luc+ 
cells. The H&E staining that tumour cells infiltrated 
into the mandibular region and thereby induced 
bone destruction (Figure 2D).
DISCUSSION
Carcinomas are malignant neoplasms derived 
from epithelial cells which are surrounded by stroma 
that interacts with cancer cells to modulate cell 
growth, migration, invasion, and tissue-specific 
gene expression. Recently studies have shown 
that interactions of tumor cells with their adjacent 
microenvironment are intimately associated with 
tumor growth and the development of metastasis. 
Therefore, appropriate in vivo animal models are 
required to study interactions between tumor cells 
and their environment. In addition, a feasible animal 
model is critical to test the effects of potential lead 
compounds.
Cancer is a complex disease in which cells 
develop aberrant proliferation and survival. The 
progression of metastasis severely increasis 
morbidity and eventually mortality. Metastatic 
tumors to the oral region are infrequent and 
account for approximately 1% of all malignant 
oral tumors27. However, metastatic tumors to the 
mandibular bone are not a rare phenomenon. Many 
Figure 1- Mouse model for metastatic breast cancer to the mandible. The growth and part of the metastatic spread (left) 
was detected by bioluminescence imaging after the injection of cancer cells. The formed metastases were quantified by 
measuring total photon flux per second (right). Data are expressed as the mean±standard error (SEM). *P<0.001 versus 
Mock group
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cases with metatastic breast carcinoma to the 
mandible have been reported and their metastases 
are well documented. Metastases in the oral region 
can occur in oral soft tissues or the mandibular 
bone. Metastatic tumors in the mandibular bone 
are more frequently reported than those in 
the oral mucosa. Primary sites are usually the 
breast, lung, intestine, ovaries, prostate, thyroid, 
kidney, testes, uterine cervix, and adrenal glan
ds9,11,12,14,15,17,19,23,24,27,30-32. Many authors reported 
that breast cancer metastasis to the oral cavity is 
more frequent for a disseminated tumor to involve 
the mandible rather than the maxilla1,21. Breast 
carcinoma is commonly osteolytic with an indistinct 
outline, but it is osteoblastic in 10% and mixed in 
type in another 10% of cases. Hormone therapy 
and sterilization may often result in the conversion 
of osteolytic lesions to the osteoblastic type2. Taken 
together, breast carcinoma has a great tendency to 
be spread by metastasis, thus it is a common clinical 
problem associated with bone destruction and a 
poorer prognosis. Breast carcinoma metastasizes 
to the mandibles three times as often as any other 
malignant tumor22. Also it has been reported that 
periodontal diseases are associated with breast 
cancer28. Therefore, a metastasis of an aggressive 
breast cancer to the mandible has a tendency to 
increase. However, the complete understanding 
is lacking about the process how breast cancer 
metastasizes to the mandibles with the most 
frequency at the cellular level. Consequently, 
diversified insights into the molecular mechanism 
of breast cancer metastasis to the mandible are 
necessary to devise preventive and therapeutic 
approaches. An appropriate animal model might 
have an additional advantage to understand the 
mechanisms underlying the metastatic process and 
to test the effects of potential lead compounds.
Due to the technical complication, there is a low 
success rate in most trials due to the susceptibility 
of bacterial contamination and the weak cellular 
activity of primary tumors as opposed to metastatic 
tumors7,20. Human tumor xenografts using the 
orthotopic transplantation of histologically intact 
tissues of several carcinomas have not been 
adopted for a metastatic animal model although 
these models represent the entire environment 
that occurs during cancer progression16. Thus, 
Figure 2- Mandible bone analysis. Radiographic images of mandibles in mice were scanned by mCT at 6 weeks. The 
osteolytic lesions were analyzed on vertical projection (slice) (A); and 3-D reconstruction images (B; upper and lower view 
each). The bone volume was determined from processed images shown in 3-D images (B); with the same given diameter 
(C). Data are expressed as the mean±standard error (SEM). *P<0.01 versus Mock group. Hematoxylin & eosin staining 
around the mandibular region was performed and the tumor-induced osteolytic site was observed. (original magnification 
×100) (B; bone, T; tumor) (D)
A
B
C
D
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xenograft models have been used to study the 
development and metastasis of human carcinomas. 
The xenograft animal model with a cultured cancer 
cell line is technically simple and reflects more 
precisely the morphology and character of their 
respective original tumor. Nevertheless, there is 
no single animal model that precisely replicates all 
of the events and circumstances that occur during 
cancer progression. The most widely used model for 
cancer development and behavior research is the 
flank model. However, not all transplanted cancer 
cells develop tumors at an atopic site due to the 
different cancer environments and no spontaneous 
metastasis does occur4. Also in case of a mammary 
fat pad xenograft, breast cancer development has 
shown a low success rate in most trials due to the 
technically limited occurrence of mammary glands 
in neonatal mice. Also, an intra-tibia inoculation of 
breast cancer is frequently applied as a cancer-bone 
metastasis model. In this model, cancer cells are 
inserted extra-capsulary through the tibial crest, 
epiphysis, and growth plate and then cells are 
sequentially injected into the bone marrow space. 
The intra-tibia model does not precisely reflect the 
characteristics of bone-invasive OSCC8,13. Thus, 
it fails to address certain aspects of the clinical 
situation. This model is not suitable to elucidate the 
cellular and molecular mechanisms of metastatic 
breast cancer to mandible and could not serve as 
suitable tool in the development of new therapeutic 
agents against metastatic breast cancer to bone.
Triple-negative breast cancer (TNBC), as defined 
by the absence of estrogen receptor, progesterone 
receptor, and human epidermal growth factor 
receptor 2 (HER2/neu) expression, can be 
particularly aggressive, and more likely to recur than 
other subtypes of breast cancer. MDA-MB-231 cell 
is triple-negative and preferentially metastasizes 
to the bone5. Particularly, metastatic MDA-MB-231 
breast cancer cells have a clinical tendency to be 
spread to mandible. Breast carcinoma metastasizes 
to the mandibles three times as often as any other 
malignant tumor12. In many types of animal models 
including tibia, MDA-MB-231 cells led to osteolytic 
bone destruction, reproducibly. Therefore, MDA-
MB-231 cell is widely used for TNBC studies. 
However, a complete understanding of how breast 
cancer metastasizes to the mandibles with the most 
frequency at the cellular level is lacking.
Above all, in this study, we tried to find a 
proper animal model of metastatic breast cancer 
to the mandibular bone. Experimental metastases 
refer to the injection of tumor cells directly to 
the systemic circulation. Metastatic breast cancer 
cells have a great tendency to be spread to bone 
including mandible. Therefore, research groups 
have been adopting the intracardiac injection 
method for osteolytic metastasis model17,18,25,26. 
Although this animal model accurately reflects 
the bone disease portion of the clinical disease, 
the complete mechanism of how breast cancer 
metastasizes to the mandibles with the most 
frequency at the cellular level is not clear. The 
active hematopoietic tissue is known as red bone 
marrow. Bones with red marrow are the favored 
sites for metastatic deposits17. Mainly in elderly 
persons, jawbones have little active marrow, while 
remnants of hematopoietic active marrow are 
detected in the posterior areas of the mandible and 
the hematopoietically active sites attract metastatic 
tumor cells. Meanwhile, the oral soft tissues have 
a rich network of capillaries which can entrap 
malignant cells. Proliferating capillaries display an 
uneven basement membrane, thereby increasing 
the penetration of tumor cells. In addition, 
inflammation plays an aggravative role in attracting 
metastatic cells to the gingiva9. In this study, firefly 
luciferase-expressing metastatic breast cancer cells 
(MDA-MB-231Luc+) were injected into the left cardiac 
ventricle producing uniform mandibular bone 
metastases with complete success rate by ex vivo 
imaging and histological analysis. Osteolytic lesions 
were widely observed in both cancellous and cortical 
bones. The subsequent histological evaluation of 
tissue sections from the mandible confirmed the 
spontaneous tumor metastasis. In animal models, 
bioluminescent imaging is a useful and sensitive 
method for detection of primary cancer growth and 
for tracking the metastasis in animal models6,10. 
In addition, luciferase-expressing cells permit the 
real-time tracking of tumor sites in living animals.
CONCLUSIONS
This study verified the reproducible xenograft 
model of metastatic breast cancer to mandibular 
bone using intracardiac injection with MDA-MB-
231Luc+. The development of breast cancer to 
mandible mouse model remains a challenge in the 
preclinical evaluation of therapies for human breast 
cancer. Now, the current xenograft model serves 
as suitable research tool and this application offers 
the preclinical assessment of anticancer therapies 
in vivo.
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